Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000419.5(ITGA2B):c.1815G>A (p.Pro605=)

Curation Version - 2.0
Curation History
JSON LD for Version 2.0

CA8602938

323551 (ClinVar)

Gene: ITGA2B

Condition: Glanzmann thrombasthenia

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: ac6a7969-418a-42b9-9a09-991c53659315

Approved on: 2022-06-13

Published on: 2022-06-13

HGVS expressions

NM_000419.5:c.1815G>A

NM_000419.5(ITGA2B):c.1815G>A (p.Pro605=)

NC_000017.11:g.44379752C>T

CM000679.2:g.44379752C>T

NC_000017.10:g.42457120C>T

CM000679.1:g.42457120C>T

NC_000017.9:g.39812646C>T

NG_008331.1:g.14754G>A

ENST00000262407.6:c.1815G>A

ENST00000648408.1:n.1246G>A

ENST00000262407.5:c.1815G>A

ENST00000592462.5:n.610G>A

NM_000419.3:c.1815G>A

NM_000419.4:c.1815G>A

Benign

BP4 BA1

Evidence Links 0

Expert Panel

Platelet Disorders VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Platelet Disorders VCEP

The c.1815G>A variant is a synonymous (silent) variant (p.Pro605=) that is not predicted by SpliceAI to impact splicing (BP4). The highest population minor allele frequency in gnomAD v3.1.2 is 0.03782 (1565/41378 alleles) in African/African American population, which is higher than the ClinGen PD VCEP threshold (>0.0024) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BA1, BP4, BP7. (VCEP specifications version 2; date of approval 4/14/2022)

BP4

The c.1815G>A (p.Pro605=) variant is a synonymous variant that is not predicted by SpliceAI to impact splicing (BP4).

BA1

The highest population minor allele frequency in gnomAD v3.1.2 is 0.03782 (1565/41378 alleles) in African/African American population, which is higher than the ClinGen PD VCEP threshold (>0.0024) for BA1, and therefore meets this criterion (BA1).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.